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Abstract 32 
 33 
Background 34 
The Prevention of Hospital Infections by Intervention and Training (PROHIBIT) survey was 35 
initiated to investigate the status of healthcare-associated infection (HAI) prevention across 36 
Europe. 37 
This paper presents the methodology of the quantitative PROHIBIT survey and outlines 38 
descriptive results related to infection control (IC) at the hospital level. 39 
 40 
Methods 41 
Hospitals in 34 European countries were invited to participate between September 2011 and 42 
March 2012. Respondents included IC clinicians and hospital management.  43 
 44 
Results 45 
Data from 309 hospitals in 24 countries were analysed. Hospitals had a median (interquartile 46 
range) of four IC nurses (2, 6) and one IC doctor (0, 2) per 1000 beds. Two-thirds (66%) of 47 
hospitals had implemented a link-nurse system. Most often, IC was an independent 48 
department (39% of hospitals), but it was also affiliated with administration (20%), 49 
microbiology (14%), or infectious diseases (7%). Almost all hospitals (96%) had defined IC 50 
objectives, which mainly addressed hand hygiene (87%), HAI reduction (84%), and antibiotic 51 
stewardship (66%). Senior management provided walk rounds in about half of hospitals, 52 
most often in Eastern and Northern Europe (65% and 64%, respectively). In the majority of 53 
hospitals (71%), sanctions were not employed for repeated violations of IC practices. Use of 54 
sanctions varied significantly by region (P < 0.001), but not by countries’ healthcare 55 
expenditure. 56 
 57 
Conclusions 58 
 59 
There is great variance in IC staffing and policies across Europe. Some areas of practice e.g. 60 
hand hygiene seem to receive considerably more attention than others equally important e.g. 61 
ABS. IC programs suffer from deficiencies in human resources and local policies which are 62 
ubiquitous concepts in determining IC performance. Strengthening of IC policies in European 63 
hospitals should be a public health priority. 64 
 65 
 66 
 67 
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Introduction 71 
Healthcare-associated infections (HAIs) are the most frequent adverse event in health care 72 
delivery and result in increased morbidity and mortality [1]. According to the European point 73 
prevalence survey (PPS), the number of patients with an HAI on any given day in European 74 
acute care hospitals is about 81,000 [2]. 75 
 76 
Various studies have shown that HAIs are partly preventable [3]. In the Study on the Efficacy 77 
of Nosocomial Infection Control (SENIC) project, infection control (IC) programs that included 78 
surveillance and control activities and trained IC personnel were strongly associated with HAI 79 
reduction [4]. Later, a consensus panel report by the Society for Healthcare Epidemiology of 80 
America defined key IC functions as follows: targeted surveillance, detection and control of 81 
outbreaks, implementing and auditing written policies, and education and training [5].  82 
 83 
In recent years, leadership, organizational mechanisms, and communication strategies have 84 
been identified as important determinants of effective practice [6-8]. The Systematic review 85 
and evidence-based guidance on organisation of hospital infection control programmes 86 
(SIGHT) project has identified components for effective IC programs; besides such factors as 87 
staffing, surveillance, audits, education, and training, the authors recommended fostering 88 
working relationships and communication across units and staff groups [9]. 89 
 90 
However, despite these findings, variations in key IC functions have been reported in multiple 91 
sources [10,11]. In 2001, the Antimicrobial Resistance Prevention and Control (ARPAC) 92 
project surveyed hospitals’ IC activities and showed that the intensity of IC programs scored 93 
higher in Northern and Western Europe than in other European regions. IC variations in 94 
Europe can be explained by differences in social and legal perspectives, and also by cultural 95 
norms [12]. The extent to which national and hospital factors influence best practice is one 96 
objective of the Prevention of Hospital Infections by Intervention and Training (PROHIBIT) 97 
study, a European Union–funded project that was launched in 2010 with the aims of 98 
understanding existing guidelines and practices for preventing HAIs, identifying factors that 99 
enable and prevent compliance with best practices, and testing the effectiveness of 100 
interventions of known efficacy [13]. 101 
 102 
This paper presents the methodology of the quantitative survey and outlines descriptive 103 
results related to the organization of IC at the hospital level in 24 European countries. 104 
 105 
Methods 106 
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The PROHIBIT survey was developed by an interdisciplinary group and comprised four 107 
questionnaires (Q1-4) that explored IC organization and activities at the hospital level (Q1), 108 
the intensive care unit level (Q2), and the non-intensive care unit level (Q3, Q4). Various 109 
professional groups were invited to answer different parts of the questionnaire (Table I). This 110 
report summarizes the findings of IC organization and activities at the hospital level (Q1). 111 
 112 
A first draft of the questionnaire was discussed with the European Centre for Disease 113 
Prevention and Control national contact points (NCPs) during a PROHIBIT expert meeting in 114 
December 2010. An advanced version was piloted in three countries in April 2011 and the 115 
final version was translated in 15 languages.  116 
 117 
NCPs invited hospitals from each country to participate in the survey between September 118 
2011 and March 2012. Hospitals’ leading IC personnel were asked to act as hospital contact 119 
points. Hospitals were offered access to the PROHIBIT results later to benchmark their IC 120 
practices with other hospitals. 121 
 122 
Hospital contact points received individualized web-based questionnaires (Limesurvey 123 
version 1.92), distributed the questionnaires within their hospitals, and organized data 124 
transfer to their NCPs. Completed anonymized paper forms were entered into the online 125 
database either by NCPs or the study center at Charité–University Medicine Berlin (CUB). 126 
Data plausibility was checked by the NCPs in collaboration with the study team at CUB. 127 
 128 
A preliminary data set was created by CUB and presented at a second PROHIBIT expert 129 
meeting in April 2012. NCPs performed further plausibility analyses and sent feedback until 130 
March 2013.  131 
 132 
A European reference data set with a maximum of 30 hospitals per country was created. In 133 
countries with more than 30 participating hospitals, 30 were selected at random for analysis 134 
by the study team at CUB.  135 
 136 
Data were stratified according to United Nations regional groupings [14] and total health care 137 
expenditure as a share of the gross domestic product (above or below the average European 138 
expenditure) [15].  139 
 140 
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Hospital characteristics were analysed descriptively. Differences between groups were 141 
tested using the Kruskal-Wallis or Wilcoxon test for continuous variables and the Chi-square 142 
test for categorical variables. Two-sided P-values of less than 0.05 were considered 143 
significant. All analyses were performed using SPSS (IBM SPSS statistics, Somer, NY, USA) 144 
and SAS (SAS Institute, Cary, NC, USA). 145 
 146 
Results 147 
Thirty-four European countries were invited to participate in the survey, of which 24 (68%) 148 
participated with a total of 529 hospitals. Data from 309 hospitals were included in the final 149 
analysis after removing hospitals from countries where more than 30 participated in the 150 
survey (Table II).  151 
 152 
Questions about IC organization were answered by the IC head (42%), an IC doctor (ICD) 153 
(30%), or an IC nurse (ICN) (28%). Questions about hospital management were answered 154 
most often by the CEO or a deputy (68%), or by administrative residents (11%). 155 
 156 
Table III summarizes the characteristics of the respondent hospitals. Hospitals had a median 157 
of eight single-room beds per 100 acute care beds, with higher numbers of single rooms in 158 
northern and Western Europe. 159 
 160 
Per 1000 beds, hospitals had a median of four ICNs and one ICD. For ICNs, data varied 161 
significantly, from 2.6 (0, 4.6) in Eastern Europe to 5.4 (2.8, 7.7) in Northern Europe. Two-162 
thirds (66%) of the hospitals had a link-nurse system in place, with the highest numbers in 163 
Northern and Western Europe (70% and 72%, respectively).  164 
 165 
Table IV shows that almost all hospitals had defined IC objectives, predominantly addressing 166 
hand hygiene (87%), HAI reduction (84%), and antibiotic stewardship (ABS) (66%). Surgical 167 
site infections, bloodstream infections, and infections due to Methicillin-resistant 168 
Staphylococcus aureus were the infection types targeted most often.  169 
 170 
Senior management provided leadership walk rounds on the wards in about half of the 171 
hospitals. 172 
 173 
Most hospitals (71%) did not use sanctions for repeated violations of IC practices (Figure 1).  174 
 175 
Discussion 176 
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We analysed data on IC structure and activities from 24 countries to determine hospitals’ IC 177 
organization and management at a broad European level. 178 
 179 
Variation in the organization of IC programs was apparent. For example, the number of 180 
available ICNs differed significantly across Europe. The lower numbers for Southern Europe 181 
were in accordance with the results of an Italian survey, which found that only 62% of 182 
hospitals had qualified ICNs [16], and a Spanish survey, which found that only 17.4% 183 
hospitals had 1 ICN per 250 beds [17].  184 
 185 
Still, overall IC staffing levels have improved slightly since the ARPAC project in 2001 (2.3 186 
ICNs per 1000 beds) [10]. Carlet and colleagues have also reported an increase in the bed-187 
to-practitioner ratio for ICNs [18]. Our identified rate of ICDs was similar to the ARPAC 188 
findings (0.94 ICD per 1,000 beds) but lower than in the European PPS (1.43 ICD per 1000 189 
beds) [2]. 190 
 191 
Current staffing levels for ICNs were similar to SENIC recommendations from 30 years ago, 192 
and it is debatable whether these recommendations are still valid [4]. Expert opinion 193 
suggests that due to increased complexity and enhanced clinical responsibility, the IC-194 
professional-per-bed rate should be 0.8 to 1 per 100 beds in acute care, and 1 per 150 to 195 
250 beds in long-term care [19, 20].  196 
 197 
Compared to ARPAC data (link nurses in 46% of the hospitals), the number of hospitals with 198 
a link nurse system had also increased but was still lower than Japan, for example, where 199 
90% of teaching hospitals and 71% of non-teaching hospitals have implemented such a 200 
system [21]. 201 
 202 
As reported by the Implementation of a training strategy for Infection Control in the European 203 
Union (TRICE) project, well-defined qualifications for IC professionals are still lacking, and 204 
many European countries still do not have adopted officially recognized qualifications for 205 
ICNs or ICDs [22], possibly explaining differences in the affiliation of IC departments and the 206 
educational background of IC heads.  207 
 208 
The median percentage of single-room beds as a proxy indicator for hospitals’ isolation 209 
capacity was lower than in the European PPS, which identified a median of 9.9% single-bed 210 
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rooms [2]. Both, the European PPS and PROHIBIT showed that the number of single-bed 211 
rooms was lowest in Eastern and Southern European countries.  212 
 213 
For the first time, hospitals’ IC objectives were surveyed, showing that almost all hospitals 214 
had defined objectives; with hand hygiene being most often mentioned, followed by HAI 215 
reduction and ABS. Interestingly, ABS was significantly more often mentioned in countries 216 
with health care expenditures below the average, which raises the issue to what extent 217 
economic concerns may drive ABS.  218 
The role of leaders in creating a positive organisational culture that helps promote good IC 219 
practice has been emphasized [9]. Leadership walk round is one example of “safety rounds“, 220 
which are promoted as a patient safety strategy in hospitals [23]. They help signify senior 221 
management’s commitment to IC. About half of the hospitals in our survey established such 222 
walk rounds, while hospital CEOs were represented only in a similar proportion of IC 223 
committees. This leaves room for improvement of active senior leaders’ engagement on IC in 224 
European hospitals.  225 
 226 
To date, there has been limited published data on hospital sanctions when IC practices are 227 
violated. Borg and colleagues showed that in hand hygiene promotion rewards were used 228 
more often than sanctions [24]. Sanctions may drive organisations or individuals to examine 229 
their activities but blame may be self-defeating, undermining transparency expectations that 230 
are central to an open safety culture [25]. 231 
 232 
As described by Wachter and Pronovost, the “no blame” model has been embraced by many 233 
hospitals, however, equally important is a culture of accountability [26]. Our findings confirm 234 
that hospitals in Europe are not willing to establish sanctions for transgressions in IC. To 235 
what extent this may interfere with accountability needs to be explored.  236 
 237 
The current survey gives insight into the IC organization of European hospitals. However, 238 
there are some limitations. 1) NCPs were involved in national surveillance activities, and 239 
hospitals were likely to be selected from such networks; 2) participation was often based on 240 
hospital motivation. Thus, data may not be completely representative for all European 241 
hospitals and IC activities may have been overestimated. 3) The United Nations geographic 242 
regions are not homogeneous in terms of GDP, healthcare organisation and culture. 243 
However, by reporting data also by country and in reference to GDP we took into account for 244 
such heterogeneity.  245 
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Our findings show that there is great variance in the staffing and IC policies across Europe. 246 
Some areas of practice e.g. hand hygiene seem to receive considerably more attention than 247 
others equally important e.g. ABS. There has been some progress in strengthening the 248 
staffing of IC however staffing levels are still suboptimal according to best practice guidance. 249 
IC programs suffer from limitations in local healthcare policies, which are ubiquitous concepts 250 
in determining IC performance [9]. Strengthening of IC policies in European hospitals should 251 
be a public health priority. 252 
 253 
 254 
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Table I Structure of the survey modules – The Prevention of Hospital Infection by 347 
Intervention and Training (PROHIBIT) survey 348 
Questionnaire Q1 Q2 Q3 Q4 
Setting Hospital level ICU level 
Medical ward 
level 
Surgical ward 
level 
Topic 
Structural and 
organisational 
parametersa 
Structural and organisational parametersb 
Organisation of IC, 
including surveillancea 
Training of health care workersb 
Shared ownership of ICa Patient safety climateb 
Management IC 
objectivesc 
CLABSI and VAP 
preventionb 
CDI and UTI 
preventionb 
SSI preventionb 
Implementation of IC practicesa 
Process and outcome parameter (AHRC and primary BSI)a 
 
349 
aProvided by leading IC personnel 350 
bProvided by head nurse of ICU/ward  351 
cProvided by hospital management/CEO  352 
 353 
AHRC: alcohol-based hand rub consumption; BSI: bloodstream infection; CDI: Clostridium difficile 354 
associated infection; CLABSI: central line associated bloodstream infection; IC: infection control; ICU: 355 
intensive care unit; PROHIBIT: Prevention of Hospital Infections by Intervention and Training; SSI: 356 
surgical site infection; UTI: urinary tract infection; VAP: ventilator-associated pneumonia. 357 
13 
 
Table II: Distribution of participating hospitals and national healthcare expenditure by country 358 
– The Prevention of Hospital Infection by Intervention and Training (PROHIBIT) survey 359 
UN geographic 
region 
Country Total HCE as % 
of GDP 
Participating 
hospitals, n 
Eastern Europe (n = 
88) 
Bulgaria 7.2 19 
Hungary 7.8 30 
Poland 7 9 
Slovakia 9 30 
Northern Europe (n = 
73) 
Finland 8.9 11 
Ireland 9.2 12 
Latvia 6.8 8 
Lithuania 7 13 
Sweden 9.6 8 
United Kingdom, England 
9.6 
5 
United Kingdom, Scotland 3 
United Kingdom, Wales 13 
Southern Europe (n 
= 83) 
Croatia 7.8 6 
Italy 9.3 18 
Malta 8.6 1 
Portugal 10.7 27 
Slovenia 9 8 
Spain 9.6 23 
Western Europe (n = 
65) 
Austria 11 8 
Belgium 10.5 5 
France 11.6 8 
Germany 11.6 30 
Switzerland 11.4 6 
The Netherlands 12 8 
All 309 
 360 
aRegional grouping used by the UN Statistics Department. [15] 361 
bHCE as the share of the GDP. [16] 362 
 363 
GDP: gross domestic product; HCE: health care expenditure; UN: United Nations. 364 
 
365 
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Table III: Characteristics of the participating hospitals stratified by United Nation regions and healthcare expenditure – The Prevention of Hospital 366 
Infection by Intervention and Training (PROHIBIT) survey 367 
Parameter 
  
Data  
available 
All 
  
Regiona HCEb 
Eastern 
Europe  
Northern 
Europe  
Southern 
Europe  
Western 
Europe  
Low HCE  High HCE 
  
Acute care beds, median (IQR) 305 368  
(200, 763) 
364  
(194, 711) 
322  
(210, 526) 
370  
(197, 763) 
423  
(181, 683) 
346  
(200, 763) 
395  
(181, 638) 
Single-room beds per 100 acute 
care bedsc,d  
286 8.0  
(3, 18) 
3.7  
(2.2, 7.7) 
12.7  
(7.2, 20.7) 
5.8  
(2.0, 18.0) 
13.3  
(6.6, 33.3) 
4.3  
(2.2, 8.5) 
12.9  
(5.6, 32.1) 
Acute care admissions, median 
(IQR) 
305 18,389  
(9761, 
31,913) 
16,790  
(9319, 
30,589) 
20,092  
(10,856, 
36,426) 
17,103  
(9853, 
29,444) 
19,260  
(8978, 
31,913) 
15,774  
(9063, 
31,156) 
20,514  
(9894, 
32,101) 
Length of stay (days)c, median (IQR) 300 6.0 (5, 7) 5.9 (5.0, 
6.6) 
4.8 (3.7, 6.5) 6.3 (5.1, 
7.7) 
6.5 (5.5, 7.3) 6.1 (5.0, 
6.7) 
6.1 (4.7, 7.3) 
Bed occupation ratec,d,e, median 
(IQR) 
296 75 (66, 86) 69 (61, 77) 79 (70, 90) 79 (70, 88) 77 (69, 87) 71 (63, 79) 80 (70, 88) 
ICN per 1000 bedsc,d, median (IQR) 297 4.0 (2.0, 
6.0) 
2.6 (0, 4.6) 5.4 (2.8, 7.7) 3.7 (2.7, 
6.3) 
3.6 (2.8, 6.4) 2.7 (0, 4.7) 4.7 (3.0, 7.3) 
ICD per 1000 beds, median (IQR) 295 1.0 (0, 2.0) 0.7 (0, 1.7) 1.4 (0.4, 2.8) 1.7 (0, 2.4) 1.1 (0, 2.4) 0.9 (0, 2.1) 1.1 (0, 2.6) 
Status of hospital         
Public 309 261 84 80 93 84 82 86 
Private 309 28 9 10 3 8 15 7 
Public and private 309 19 6 10 3 7 3 7 
Type of hospital         
Primary carec 309 69 22 34 18 12 25 27 
Secondary care 309 125 40 38 47 43 34 40 
Tertiary care 309 105 34 27 32 40 38 28 
Specialized care 309 7 2 0 3 5 2 3 
University hospitalc 309 100 32 24 36 47 22 27 
IC department affiliated with         
Nursing 309 33 11 7 18 5 15 5 
Infectious diseases 309 22 7 6 8 10 5 9 
Microbiology 309 42 14 10 15 16 14 10 
15 
 
Own department 309 119 39 41 36 40 37 40 
Administrationc,d 309 62 20 31 14 19 14 30 
Otherc 309 74 24 19 18 35 23 19 
IC head’s educational background         
Nursingc,d 309 42 14 7 23 6 22 4 
Medicinec,d 309 180 58 64 53 77 32 67 
Microbiologyc 309 29 9 6 7 8 19 8 
Epidemiologyc,d 309 23 7 16 8 4 0 14 
Epidemiology and nursing 309 5 2 1 1 4 0 1 
Epidemiology and medicinec 309 34 11 14 1 19 6 10 
Epidemiology and microbiology 309 10 3 3 0 6 3 2 
IC team has direct access to 
microbiology data c,d 
309 187 61 45 67 61 72 50 
Hospital has an IC committeec,d 308 279 91 94 74 99 94 86 
Members of the IC committee                
Administrative director/CEO and/or 
deputyc 
279 120 43 39 57 23 64 37 
Medical directorc 279 181 65 71 60 51 79 69 
Nursing directorc,d 279 198 71 83 70 50 82 78 
ICD and/or ICNc,d 279 268 96 92 94 99 100 90 
ICDc 279 234 84 88 79 95 67 88 
ICNc,d 279 230 82 54 91 94 98 62 
Microbiologistc 279 225 81 76 87 95 62 77 
Pharmacistc,d 279 194 70 65 68 83 59 57 
Link-nurse system established  309 204 66 65 70 59 72 64 
 368 
CEO: chief executive officer; GDP: gross domestic product; HCE: health care expenditure; IC: infection control; ICN: infection control nurse; ICD: infection control 369 
doctor; IQR: interquartile range; PROHIBIT: Prevention of Hospital Infections by Intervention and Training; UN: United Nations. 370 
 371 
Values in the table are percentages unless otherwise indicated. 372 
 
373 
aGeographic regions according to UN grouping [15]; Eastern Europe (n = 88), Northern Europe (n = 73), Southern Europe (n = 83), Western Europe (n = 65). 374 
bLow/high HCE defined as the share of the GDP ≤/> the European mean in 2010 (9%) [16]; low HCE (n = 135), high HCE (n = 174). 375 
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cDifferences between UN regions P < 0.05 (Kruskal-Wallis test or Chi-square). 376 
dDifferences between low/high HCE P < 0.05 (Wilcoxon test or Chi-square). 377 
eNumber of patient days per 100 bed days. 378 
 
379 
 
380 
 381 
 382 
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Table IV: Infection control objectives of the participating hospitals stratified by United Nation regions and healthcare expenditure – The Prevention 383 
of Hospital Infection by Intervention and Training (PROHIBIT) survey 384 
Parameter 
  
  
Data 
available 
All Regiona HCEb 
Eastern 
Europe 
Northern 
Europe 
Southern 
Europe 
Western 
Europe 
Low 
HCE 
High 
HCE 
N % % % % % % % 
IC objectives defined in 2010                    Hospital-wide 275 244 89 93 90 90 80 89 88  In specific units 275 19 7 4 3 10 11 5 8  No objectives defined 275 12 4 4 7 0 9 6 3 
Objectives defined                     Improvement of hand hygiene 275 239 87 82 92 91 83 83 90  Increase of AHRCc 275 139 51 48 39 65 46 49 52  ABSc,d 275 181 66 87 81 54 33 82 53 
If ABS, reasons                   
i) ABS is part of surveillancec 181 139 77 70 94 69 78 72 83 
ii) ABS is part of mandatory surveillance 181 63 16 33 38 31 44 33 37 
iii) High MDRO rates 181 29 35 19 4 24 17 19 12 
iv) Own initiativec 181 65 36 37 21 50 39 37 34  Reduction of infection ratesc 275 230 84 87 86 90 67 85 82 
o Reduction of BSIc 275 180 65 73 69 68 46 65 66 
If reduction of BSI, reasons                   
i) BSI is part of surveillance  180 131 73 79 71 70 68 75 68 
ii) BSI is part of mandatory surveillancec,d 180 83 46 62 51 34 24 57 38 
iii) High BSI rates 180 13 7 5 2 11 12 4 10 
iv) Own initiativec 180 47 26 23 12 40 28 25 27 
o Reduction of VAPc,d 275 147 53 69 49 53 35 60 48 
If reduction of VAP, reasons                   
i) VAP is part of surveillance  147 106 72 72 59 76 84 74 70 
ii) VAP is part of mandatory surveillance 147 53 36 40 38 42 11 37 35 
iii) High VAP rates 147 19 13 10 7 20 16 11 15 
iv) Own initiative 147 42 29 29 14 39 26 29 28 
o Reduction of SSIc 275 183 67 79 66 65 50 71 63 
If reduction of SSI, reasons                   
i) SSI is part of surveillance  183 131 72 70 72 71 78 70 73 
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ii) SSI is part of mandatory surveillance 183 76 42 42 41 35 52 42 41 
iii) High SSI ratesd 183 22 12 6 13 22 7 7 17 
iv) Own initiativec 183 56 31 35 15 43 19 35 28 
o Reduction of UTIc,d 275 133 48 69 37 45 33 60 40 
If reduction of UTI, reasons                   
i) UTI is part of surveillance  133 97 73 74 73 71 72 75 71 
ii) UTI is part of mandatory surveillance 133 40 30 41 37 23 0 42 16 
iii) High UTI rates 133 11 8 5 5 14 11 6 12 
iv) Own initiative 133 45 34 31 23 43 39 32 36 
o Reduction of MRSAc 275 172 63 69 73 63 41 67 59 
If reduction of MRSA, reasons                   
i) MRSA is part of surveillance  172 128 74 72 81 73 68 79 70 
ii) MRSA is part of mandatory surveillance 172 84 49 53 61 41 32 56 43 
iii) High MRSA rates 172 12 7 5 5 10 9 4 10 
iv) Own initiativec 172 43 25 22 2 45 32 17 34 
o Reduction of CDIc 275 121 44 39 68 35 39 39 48 
If reduction of CDI, reasons                   
i) CDI is part of surveillance  121 79 65 49 70 78 67 60 69 
ii) CDI is part of mandatory surveillance 121 53 44 46 65 30 19 51 39 
iii) High CDI rates 121 12 10 12 8 7 14 11 10 
iv) Own initiativec,d 121 33 27 18 8 56 43 17 34 
Hospital management offers walk roundsa,c 275 148 54 63 63 37 53 59 50 
Results of walk rounds recorded in writingd 144 107 74 65 83 70 83 65 83 
 385 
ABS: antibiotic stewardship; AHRC: alcohol-based hand rub consumption; BSI: bloodstream infection; CDI: Clostridium difficile associated infection; HCE: health 386 
care expenditure; IC: infection control; PROHIBIT: Prevention of Hospital Infections by Intervention and Training; MDRO: multidrug-resistant organisms; MRSA: 387 
methicillin-resistant Staphylococcus aureus; SSI: surgical site infection; UTI: urinary tract infection; VAP: ventilator-associated pneumonia.  388 
 389 
In 275 (89%) of 309 hospitals participating in PROHIBIT, data were available from the hospital management on IC objectives. Values in the table are percentages 390 
unless otherwise indicated.  391 
 392 
aGeographic regions according to UN grouping [15]; Eastern Europe (n = 88), Northern Europe (n = 73), Southern Europe (n = 83), Western Europe (n = 65) 393 
bLow/high HCE defined as the share of the GDP ≤/> the European mean in 2010 (9%) [16]; low HCE (n = 135), high HCE (n = 174). 394 
cDifferences between UN regions P<0.05 (Chi-square).  395 
dDifferences between low/high HCE P<0.05 (Chi-square). 396 
 397 
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Figure 1 Accountability of repeated violation (sanctions) of infection control practices in participating hospitals stratified by United Nation regions 398 
and healthcare expenditure – The Prevention of Hospital Infection by Intervention and Training (PROHIBIT) survey 399 
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 [Figure legend] 403 
 404 
 405 
 406 
Figure 1 407 
United Nation regions [15]: Eastern Europe (n = 88), Northern Europe (n = 73), Southern Europe (n = 83), Western Europe (n = 65), P < 0.001.  408 
Low/high healthcare expenditure (HCE) defined as the share of the gross domestic product (GDP) ≤/> the European mean in 2010 (9%) [16]: low 409 
HCE (n = 135), high HCE (n = 174), P = 0.286.  410 
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